NO932148D0 - fusion polypeptides - Google Patents

fusion polypeptides

Info

Publication number: NO932148D0
Authority: NO; Norway
Prior art keywords: fusion polypeptides; polypeptides; fusion
Prior art date: 1990-12-13

Application number

NO932148A

Other languages

Norwegian (no)

Other versions

NO932148L (en

Inventor

Teresa M Kubiak

Satish K Sharma

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-13

Filing date

1993-06-11

Publication date

1993-06-11

1993-06-11 Application filed by Upjohn Co filed Critical Upjohn Co

1993-06-11 Publication of NO932148D0 publication Critical patent/NO932148D0/en

1993-08-09 Publication of NO932148L publication Critical patent/NO932148L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Vascular Medicine (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO93932148A 1990-12-13 1993-06-11 fusion polypeptides NO932148L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62672790A	1990-12-13	1990-12-13
PCT/US1991/009152 WO1992010576A1 (en)	1990-12-13	1991-12-12	Fusion polypeptides

Publications (2)

Publication Number	Publication Date
NO932148D0 true NO932148D0 (en)	1993-06-11
NO932148L NO932148L (en)	1993-08-09

Family

ID=24511577

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO93932148A NO932148L (en)	1990-12-13	1993-06-11	fusion polypeptides

Country Status (13)

Country	Link
EP (1)	EP0561971A1 (en)
JP (1)	JPH06503473A (en)
AU (1)	AU662508B2 (en)
CA (1)	CA2094512A1 (en)
CZ (1)	CZ109393A3 (en)
FI (1)	FI932680L (en)
HU (1)	HUT69963A (en)
IE (1)	IE914347A1 (en)
NO (1)	NO932148L (en)
RU (1)	RU2114119C1 (en)
SK (1)	SK60893A3 (en)
TW (1)	TW213923B (en)
WO (1)	WO1992010576A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9906715D0 (en) *	1999-03-23	1999-05-19	Ferring Bv	Compositions for promoting growth
US20050272652A1 (en)	1999-03-29	2005-12-08	Gault Victor A	Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
US6759393B1 (en)	1999-04-12	2004-07-06	Pfizer Inc.	Growth hormone and growth hormone releasing hormone compositions
JP2000350590A (en) *	1999-04-12	2000-12-19	Pfizer Prod Inc	Growth hormone and growth hormone releasing hormone composition
AU784477B2 (en)	1999-11-19	2006-04-13	Shire Human Genetic Therapies, Inc.	Nucleic acid construct for optimized production of products
GB0010188D0 (en) *	2000-04-26	2000-06-14	Ferring Bv	Inhibitors of dipeptidyl peptidase IV
EP1205551A1 (en) *	2000-11-09	2002-05-15	Pfizer Products Inc.	Growth hormone and growth hormone releasing hormone compositions
US6992174B2 (en) *	2001-03-30	2006-01-31	Emd Lexigen Research Center Corp.	Reducing the immunogenicity of fusion proteins
DK1454138T3 (en) *	2001-12-04	2012-02-13	Merck Patent Gmbh	Immunocytokines with modulated selectivity
GB2384001B (en) *	2001-12-14	2004-02-04	Asterion Ltd	Chimeric growth hormone-growth hormone receptor proteins
EP1694356B1 (en)	2003-12-09	2011-02-16	Novo Nordisk A/S	Regulation of food preference using glp-1 agonists
EP2316446A1 (en)	2004-06-11	2011-05-04	Novo Nordisk A/S	Counteracting drug-induced obesity using GLP-1 agonists
AU2006213607A1 (en)	2005-02-11	2006-08-17	Amylin Pharmaceuticals, Llc	GIP analog and hybrid polypeptides with selectable properties
US8263545B2 (en)	2005-02-11	2012-09-11	Amylin Pharmaceuticals, Inc.	GIP analog and hybrid polypeptides with selectable properties
US7855279B2 (en)	2005-09-27	2010-12-21	Amunix Operating, Inc.	Unstructured recombinant polymers and uses thereof
WO2007103515A2 (en) †	2006-03-06	2007-09-13	Amunix, Inc.	Unstructured recombinant polymers and uses thereof
US8497240B2 (en)	2006-08-17	2013-07-30	Amylin Pharmaceuticals, Llc	DPP-IV resistant GIP hybrid polypeptides with selectable properties
US20110046060A1 (en)	2009-08-24	2011-02-24	Amunix Operating, Inc.,	Coagulation factor IX compositions and methods of making and using same
PL2393828T3 (en)	2009-02-03	2017-06-30	Amunix Operating Inc.	Extended recombinant polypeptides and compositions comprising same
EP2528935B1 (en)	2010-01-29	2019-03-27	Archer-Daniels-Midland Company	Peptide domains that bind small molecules of industrial significance
CN119192402A (en)	2012-02-15	2024-12-27	比奥贝拉蒂治疗公司	Factor VIII compositions and methods of making and using the same
WO2013123457A1 (en)	2012-02-15	2013-08-22	Biogen Idec Ma Inc.	Recombinant factor viii proteins
WO2015023891A2 (en)	2013-08-14	2015-02-19	Biogen Idec Ma Inc.	Factor viii-xten fusions and uses thereof
CA2994547A1 (en)	2015-08-03	2017-02-09	Bioverativ Therapeutics Inc.	Factor ix fusion proteins and methods of making and using same
US12161696B2 (en)	2016-12-02	2024-12-10	Bioverativ Therapeutics Inc.	Methods of treating hemophilic arthropathy using chimeric clotting factors
KR102398777B1 (en) *	2017-06-29	2022-05-17	유레카 에스에이알엘	Prodrug peptides with improved pharmaceutical properties
TW202015723A (en)	2018-05-18	2020-05-01	美商百歐維拉提夫治療公司	Methods of treating hemophilia a

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4703004A (en) *	1984-01-24	1987-10-27	Immunex Corporation	Synthesis of protein with an identification peptide
US4569794A (en) *	1984-12-05	1986-02-11	Eli Lilly And Company	Process for purifying proteins and compounds useful in such process
US4734399A (en) *	1985-08-06	1988-03-29	Hoffmann-La Roche Inc.	Growth hormone releasing factor analogs
CA1340522C (en) *	1987-03-10	1999-05-04	Heinz Dobeli	Fusion proteins containing neighbouring histidines for improved purification
DK0477217T3 (en) *	1989-06-16	1995-04-03	Upjohn Co	Stabilized potent GRF analogs
ATE139572T1 (en) *	1990-04-09	1996-07-15	Upjohn Co	METHOD FOR PURIFYING RECOMBINANT PROTEINS AND USEFUL PRODUCTS THEREFOR

1991
- 1991-12-12 SK SK60893A patent/SK60893A3/en unknown
- 1991-12-12 EP EP92901817A patent/EP0561971A1/en not_active Withdrawn
- 1991-12-12 FI FI932680A patent/FI932680L/en not_active Application Discontinuation
- 1991-12-12 CA CA002094512A patent/CA2094512A1/en not_active Abandoned
- 1991-12-12 JP JP4501996A patent/JPH06503473A/en active Pending
- 1991-12-12 CZ CS931093A patent/CZ109393A3/en unknown
- 1991-12-12 AU AU91165/91A patent/AU662508B2/en not_active Ceased
- 1991-12-12 RU RU93045577A patent/RU2114119C1/en active
- 1991-12-12 WO PCT/US1991/009152 patent/WO1992010576A1/en not_active Ceased
- 1991-12-12 HU HU9301705A patent/HUT69963A/en unknown
- 1991-12-13 IE IE434791A patent/IE914347A1/en not_active Application Discontinuation
- 1991-12-17 TW TW080109839A patent/TW213923B/zh active
1993
- 1993-06-11 NO NO93932148A patent/NO932148L/en unknown

Also Published As

Publication number	Publication date
JPH06503473A (en)	1994-04-21
HUT69963A (en)	1995-09-28
EP0561971A1 (en)	1993-09-29
IE914347A1 (en)	1992-06-17
FI932680A7 (en)	1993-06-11
CA2094512A1 (en)	1992-06-14
WO1992010576A1 (en)	1992-06-25
TW213923B (en)	1993-10-01
FI932680A0 (en)	1993-06-11
FI932680L (en)	1993-06-11
AU9116591A (en)	1992-07-08
NO932148L (en)	1993-08-09
HU9301705D0 (en)	1993-10-28
SK60893A3 (en)	1993-10-06
AU662508B2 (en)	1995-09-07
CZ109393A3 (en)	1994-01-19
RU2114119C1 (en)	1998-06-27

Publication	Publication Date	Title
BG94328A (en)	1993-12-24	POLYPEPTIDES
NO932148D0 (en)	1993-06-11	fusion polypeptides
FI20002013L (en)	2000-09-13	HCV fusion protein
FI925852L (en)	1992-12-23	AEROSOLCOMPOSITIONER UNDER TRYCK
DK162890D0 (en)	1990-07-06	POLYPEPTIDE
NO983400L (en)	1991-07-16	Oppfiskingsverkt ° y
FI923800L (en)	1992-08-24	SYNTHETIC POLYPEPTIDES
FR2650644B1 (en)	1994-05-13	HOMOCINETIC JOINT
DE69329145D1 (en)	2000-09-07	Anti-viral fusion peptides
DE69120700D1 (en)	1996-08-14	Pair of polypeptides
FI923416A7 (en)	1992-07-29	Azeotropy-assisted transvinylation technology
DK284489A (en)	1989-12-11	FUSION PROTEINS
FI925143L (en)	1992-11-14	FOERFARANDE FOER EXPRESSION AV POLYPEPTIDES
FI891907A7 (en)	1989-10-23	Lens
KR920008084U (en)	1992-05-19	Seam
IT1243098B (en)	1994-05-24	JOINT
ATA200090A (en)	1991-06-15	PIANINO
FI930108A0 (en)	1993-01-12	Imidazopyridine-PAF antagonists
KR910020454U (en)	1991-12-20	Joint
KR910018223U (en)	1991-11-28	Assembly container
FI912827A7 (en)	1991-12-14	Crystalline polypeptides
NO923573L (en)	1992-11-12	SYNTHETIC POLYPEPTIDES
KR910018928U (en)	1991-11-29	Fuse
FR2649773B1 (en)	1992-10-02	IMPERDABLE JOINT
DK236190D0 (en)	1990-10-01	POLYPEPTIDE